Sen. Dick Durbin (D-IL) (J. Scott Applewhite, File/AP Images)
February 17, 2022 01:22 PM ESTUpdated 01:45 PM
Bioregnum
Pharma

US sen­a­tor blasts J&J's Texas two-step bank­rupt­cy as the phar­ma gi­ant twists in the pub­lic spot­light

J&J has chore­o­graphed a le­gal dance that has tak­en the phar­ma gi­ant straight in­to the wait­ing arms of a US sen­a­tor. And the law­mak­er has …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Sarep­ta li­cens­es Ar­row­head­'s RNA-based rare dis­ease pipeline, promis­ing big biobucks

Up­dat­ed: Roche buys out CAR-T part­ner Po­sei­da for $1B up­front

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times